GlassScriptPhysician profile
Archana Bhargava
NPI 1366457004
$900.35
in general payments reported to CMS, 2019-2025
18 companies · $41.35 in 2025
The $41.35 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $785 · 2020: $38.18 · 2021: $35.85 · 2025: $41.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $25.95 · Food and Beverage: $15.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $25.95 |
| Food and Beverage | $15.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $249.94 | 2019 | |
| Pfizer INC. | $158.19 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $61.37 | 2019-2025 | Enhertu |
| Takeda Pharmaceuticals U.S.A., INC. | $49.09 | 2019-2025 | Ninlaro |
| Lilly USA, LLC | $48.43 | 2019 | |
| Celgene Corporation | $42.11 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $39.21 | 2019 | |
| Janssen Biotech, INC. | $37.95 | 2019 | |
| Merck Sharp & Dohme LLC | $34.33 | 2019 | |
| Amgen INC. | $33.67 | 2019 | |
| Rigel Pharmaceuticals, INC. | $26.74 | 2019 | |
| Myovant Sciences INC. | $23.93 | 2021 | |
| Karyopharm Therapeutics INC. | $18.24 | 2020 | |
| Alexion Pharmaceuticals, INC. | $17.68 | 2019 | |
| Eisai INC. | $17.55 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $15.45 | 2019 | |
| Exelixis INC. | $14.55 | 2019 | |
| Gilead Sciences, INC. | $11.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Archana Bhargava listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.